Covid-19 Impact on Androgen Replacement Therapy Market, Global Research Reports 2020-2021
This report covers market size and forecasts of Androgen Replacement Therapy, including the following market information:
Major competitors identified in this market include AbbVie, Endo International, Eli lilly, Pfizer, Actavis (Allergan), Bayer, Novartis, Teva, Mylan, Upsher-Smith, Ferring Pharmaceuticals, Kyowa Kirin, Acerus Pharmaceuticals, etc.
Based on the Region:
- Global Androgen Replacement Therapy Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Androgen Replacement Therapy Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Androgen Replacement Therapy Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Androgen Replacement Therapy Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Major competitors identified in this market include AbbVie, Endo International, Eli lilly, Pfizer, Actavis (Allergan), Bayer, Novartis, Teva, Mylan, Upsher-Smith, Ferring Pharmaceuticals, Kyowa Kirin, Acerus Pharmaceuticals, etc.
Based on the Region:
- Asia-Pacific (China, Japan, South Korea, India and ASEAN)
- North America (US and Canada)
- Europe (Germany, France, UK and Italy)
- Rest of World (Latin America, Middle East & Africa)
- Gels
- Injections
- Patches
- Other
- Hospitals
- Clinics
- Others
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Androgen Replacement Therapy Industry
1.7 COVID-19 Impact: Androgen Replacement Therapy Market Trends
2 GLOBAL ANDROGEN REPLACEMENT THERAPY QUARTERLY MARKET SIZE ANALYSIS
2.1 Androgen Replacement Therapy Business Impact Assessment - COVID-19
2.1.1 Global Androgen Replacement Therapy Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Androgen Replacement Therapy Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Androgen Replacement Therapy Quarterly Market Size, 2019 VS 2020
3.2 By Players, Androgen Replacement Therapy Headquarters and Area Served
3.3 Date of Key Players Enter into Androgen Replacement Therapy Market
3.4 Key Players Androgen Replacement Therapy Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON ANDROGEN REPLACEMENT THERAPY SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Gels
1.4.2 Injections
1.4.3 Patches
1.4.4 Other
4.2 By Type, Global Androgen Replacement Therapy Market Size, 2019-2021
5 IMPACT OF COVID-19 ON ANDROGEN REPLACEMENT THERAPY SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Hospitals
5.5.2 Clinics
5.5.3 Others
5.2 By Application, Global Androgen Replacement Therapy Market Size, 2019-2021
5.2.1 By Application, Global Androgen Replacement Therapy Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 AbbVie
7.1.1 AbbVie Business Overview
7.1.2 AbbVie Androgen Replacement Therapy Quarterly Revenue, 2020
7.1.3 AbbVie Androgen Replacement Therapy Product Introduction
7.1.4 AbbVie Response to COVID-19 and Related Developments
7.2 Endo International
7.2.1 Endo International Business Overview
7.2.2 Endo International Androgen Replacement Therapy Quarterly Revenue, 2020
7.2.3 Endo International Androgen Replacement Therapy Product Introduction
7.2.4 Endo International Response to COVID-19 and Related Developments
7.3 Eli lilly
7.3.1 Eli lilly Business Overview
7.3.2 Eli lilly Androgen Replacement Therapy Quarterly Revenue, 2020
7.3.3 Eli lilly Androgen Replacement Therapy Product Introduction
7.3.4 Eli lilly Response to COVID-19 and Related Developments
7.4 Pfizer
7.4.1 Pfizer Business Overview
7.4.2 Pfizer Androgen Replacement Therapy Quarterly Revenue, 2020
7.4.3 Pfizer Androgen Replacement Therapy Product Introduction
7.4.4 Pfizer Response to COVID-19 and Related Developments
7.5 Actavis (Allergan)
7.5.1 Actavis (Allergan) Business Overview
7.5.2 Actavis (Allergan) Androgen Replacement Therapy Quarterly Revenue, 2020
7.5.3 Actavis (Allergan) Androgen Replacement Therapy Product Introduction
7.5.4 Actavis (Allergan) Response to COVID-19 and Related Developments
7.6 Bayer
7.6.1 Bayer Business Overview
7.6.2 Bayer Androgen Replacement Therapy Quarterly Revenue, 2020
7.6.3 Bayer Androgen Replacement Therapy Product Introduction
7.6.4 Bayer Response to COVID-19 and Related Developments
7.7 Novartis
7.7.1 Novartis Business Overview
7.7.2 Novartis Androgen Replacement Therapy Quarterly Revenue, 2020
7.7.3 Novartis Androgen Replacement Therapy Product Introduction
7.7.4 Novartis Response to COVID-19 and Related Developments
7.8 Teva
7.8.1 Teva Business Overview
7.8.2 Teva Androgen Replacement Therapy Quarterly Revenue, 2020
7.8.3 Teva Androgen Replacement Therapy Product Introduction
7.8.4 Teva Response to COVID-19 and Related Developments
7.9 Mylan
7.9.1 Mylan Business Overview
7.9.2 Mylan Androgen Replacement Therapy Quarterly Revenue, 2020
7.9.3 Mylan Androgen Replacement Therapy Product Introduction
7.9.4 Mylan Response to COVID-19 and Related Developments
7.10 Upsher-Smith
7.10.1 Upsher-Smith Business Overview
7.10.2 Upsher-Smith Androgen Replacement Therapy Quarterly Revenue, 2020
7.10.3 Upsher-Smith Androgen Replacement Therapy Product Introduction
7.10.4 Upsher-Smith Response to COVID-19 and Related Developments
7.11 Ferring Pharmaceuticals
7.11.1 Ferring Pharmaceuticals Business Overview
7.11.2 Ferring Pharmaceuticals Androgen Replacement Therapy Quarterly Revenue, 2020
7.11.3 Ferring Pharmaceuticals Androgen Replacement Therapy Product Introduction
7.11.4 Ferring Pharmaceuticals Response to COVID-19 and Related Developments
7.12 Kyowa Kirin
7.12.1 Kyowa Kirin Business Overview
7.12.2 Kyowa Kirin Androgen Replacement Therapy Quarterly Revenue, 2020
7.12.3 Kyowa Kirin Androgen Replacement Therapy Product Introduction
7.12.4 Kyowa Kirin Response to COVID-19 and Related Developments
7.13 Acerus Pharmaceuticals
7.13.1 Acerus Pharmaceuticals Business Overview
7.13.2 Acerus Pharmaceuticals Androgen Replacement Therapy Quarterly Revenue, 2020
7.13.3 Acerus Pharmaceuticals Androgen Replacement Therapy Product Introduction
7.13.4 Acerus Pharmaceuticals Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Androgen Replacement Therapy Industry
1.7 COVID-19 Impact: Androgen Replacement Therapy Market Trends
2 GLOBAL ANDROGEN REPLACEMENT THERAPY QUARTERLY MARKET SIZE ANALYSIS
2.1 Androgen Replacement Therapy Business Impact Assessment - COVID-19
2.1.1 Global Androgen Replacement Therapy Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Androgen Replacement Therapy Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Androgen Replacement Therapy Quarterly Market Size, 2019 VS 2020
3.2 By Players, Androgen Replacement Therapy Headquarters and Area Served
3.3 Date of Key Players Enter into Androgen Replacement Therapy Market
3.4 Key Players Androgen Replacement Therapy Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON ANDROGEN REPLACEMENT THERAPY SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Gels
1.4.2 Injections
1.4.3 Patches
1.4.4 Other
4.2 By Type, Global Androgen Replacement Therapy Market Size, 2019-2021
5 IMPACT OF COVID-19 ON ANDROGEN REPLACEMENT THERAPY SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Hospitals
5.5.2 Clinics
5.5.3 Others
5.2 By Application, Global Androgen Replacement Therapy Market Size, 2019-2021
5.2.1 By Application, Global Androgen Replacement Therapy Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 AbbVie
7.1.1 AbbVie Business Overview
7.1.2 AbbVie Androgen Replacement Therapy Quarterly Revenue, 2020
7.1.3 AbbVie Androgen Replacement Therapy Product Introduction
7.1.4 AbbVie Response to COVID-19 and Related Developments
7.2 Endo International
7.2.1 Endo International Business Overview
7.2.2 Endo International Androgen Replacement Therapy Quarterly Revenue, 2020
7.2.3 Endo International Androgen Replacement Therapy Product Introduction
7.2.4 Endo International Response to COVID-19 and Related Developments
7.3 Eli lilly
7.3.1 Eli lilly Business Overview
7.3.2 Eli lilly Androgen Replacement Therapy Quarterly Revenue, 2020
7.3.3 Eli lilly Androgen Replacement Therapy Product Introduction
7.3.4 Eli lilly Response to COVID-19 and Related Developments
7.4 Pfizer
7.4.1 Pfizer Business Overview
7.4.2 Pfizer Androgen Replacement Therapy Quarterly Revenue, 2020
7.4.3 Pfizer Androgen Replacement Therapy Product Introduction
7.4.4 Pfizer Response to COVID-19 and Related Developments
7.5 Actavis (Allergan)
7.5.1 Actavis (Allergan) Business Overview
7.5.2 Actavis (Allergan) Androgen Replacement Therapy Quarterly Revenue, 2020
7.5.3 Actavis (Allergan) Androgen Replacement Therapy Product Introduction
7.5.4 Actavis (Allergan) Response to COVID-19 and Related Developments
7.6 Bayer
7.6.1 Bayer Business Overview
7.6.2 Bayer Androgen Replacement Therapy Quarterly Revenue, 2020
7.6.3 Bayer Androgen Replacement Therapy Product Introduction
7.6.4 Bayer Response to COVID-19 and Related Developments
7.7 Novartis
7.7.1 Novartis Business Overview
7.7.2 Novartis Androgen Replacement Therapy Quarterly Revenue, 2020
7.7.3 Novartis Androgen Replacement Therapy Product Introduction
7.7.4 Novartis Response to COVID-19 and Related Developments
7.8 Teva
7.8.1 Teva Business Overview
7.8.2 Teva Androgen Replacement Therapy Quarterly Revenue, 2020
7.8.3 Teva Androgen Replacement Therapy Product Introduction
7.8.4 Teva Response to COVID-19 and Related Developments
7.9 Mylan
7.9.1 Mylan Business Overview
7.9.2 Mylan Androgen Replacement Therapy Quarterly Revenue, 2020
7.9.3 Mylan Androgen Replacement Therapy Product Introduction
7.9.4 Mylan Response to COVID-19 and Related Developments
7.10 Upsher-Smith
7.10.1 Upsher-Smith Business Overview
7.10.2 Upsher-Smith Androgen Replacement Therapy Quarterly Revenue, 2020
7.10.3 Upsher-Smith Androgen Replacement Therapy Product Introduction
7.10.4 Upsher-Smith Response to COVID-19 and Related Developments
7.11 Ferring Pharmaceuticals
7.11.1 Ferring Pharmaceuticals Business Overview
7.11.2 Ferring Pharmaceuticals Androgen Replacement Therapy Quarterly Revenue, 2020
7.11.3 Ferring Pharmaceuticals Androgen Replacement Therapy Product Introduction
7.11.4 Ferring Pharmaceuticals Response to COVID-19 and Related Developments
7.12 Kyowa Kirin
7.12.1 Kyowa Kirin Business Overview
7.12.2 Kyowa Kirin Androgen Replacement Therapy Quarterly Revenue, 2020
7.12.3 Kyowa Kirin Androgen Replacement Therapy Product Introduction
7.12.4 Kyowa Kirin Response to COVID-19 and Related Developments
7.13 Acerus Pharmaceuticals
7.13.1 Acerus Pharmaceuticals Business Overview
7.13.2 Acerus Pharmaceuticals Androgen Replacement Therapy Quarterly Revenue, 2020
7.13.3 Acerus Pharmaceuticals Androgen Replacement Therapy Product Introduction
7.13.4 Acerus Pharmaceuticals Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
LIST OF TABLES
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Androgen Replacement Therapy Assessment
Table 9. COVID-19 Impact: Androgen Replacement Therapy Market Trends
Table 10. COVID-19 Impact Global Androgen Replacement Therapy Market Size
Table 11. Global Androgen Replacement Therapy Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Androgen Replacement Therapy Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Androgen Replacement Therapy Market Growth Drivers
Table 14. Global Androgen Replacement Therapy Market Restraints
Table 15. Global Androgen Replacement Therapy Market Opportunities
Table 16. Global Androgen Replacement Therapy Market Challenges
Table 17. By Players, Androgen Replacement Therapy Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Androgen Replacement Therapy Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Androgen Replacement Therapy Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Androgen Replacement Therapy Market
Table 21. Key Players Androgen Replacement Therapy Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Androgen Replacement Therapy Market Size 2019-2021, (US$ Million)
Table 24. Global Androgen Replacement Therapy Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Androgen Replacement Therapy Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 57. AbbVie Business Overview
Table 58. AbbVie Androgen Replacement Therapy Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. AbbVie Androgen Replacement Therapy Product
Table 60. AbbVie Response to COVID-19 and Related Developments
Table 61. Endo International Business Overview
Table 62. Endo International Androgen Replacement Therapy Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Endo International Androgen Replacement Therapy Product
Table 64. Endo International Response to COVID-19 and Related Developments
Table 65. Eli lilly Business Overview
Table 66. Eli lilly Androgen Replacement Therapy Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Eli lilly Androgen Replacement Therapy Product
Table 68. Eli lilly Response to COVID-19 and Related Developments
Table 69. Pfizer Business Overview
Table 70. Pfizer Androgen Replacement Therapy Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Pfizer Androgen Replacement Therapy Product
Table 72. Pfizer Response to COVID-19 and Related Developments
Table 73. Actavis (Allergan) Business Overview
Table 74. Actavis (Allergan) Androgen Replacement Therapy Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Actavis (Allergan) Androgen Replacement Therapy Product
Table 76. Actavis (Allergan) Response to COVID-19 and Related Developments
Table 77. Bayer Business Overview
Table 78. Bayer Androgen Replacement Therapy Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Bayer Androgen Replacement Therapy Product
Table 80. Bayer Response to COVID-19 and Related Developments
Table 81. Novartis Business Overview
Table 82. Novartis Androgen Replacement Therapy Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Novartis Androgen Replacement Therapy Product
Table 84. Novartis Response to COVID-19 and Related Developments
Table 85. Teva Business Overview
Table 86. Teva Androgen Replacement Therapy Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Teva Androgen Replacement Therapy Product
Table 88. Teva Response to COVID-19 and Related Developments
Table 89. Mylan Business Overview
Table 90. Mylan Androgen Replacement Therapy Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Mylan Androgen Replacement Therapy Product
Table 92. Mylan Response to COVID-19 and Related Developments
Table 93. Upsher-Smith Business Overview
Table 94. Upsher-Smith Androgen Replacement Therapy Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Upsher-Smith Androgen Replacement Therapy Product
Table 96. Upsher-Smith Response to COVID-19 and Related Developments
Table 97. Ferring Pharmaceuticals Business Overview
Table 98. Ferring Pharmaceuticals Androgen Replacement Therapy Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Ferring Pharmaceuticals Androgen Replacement Therapy Product
Table 100. Ferring Pharmaceuticals Response to COVID-19 and Related Developments
Table 101. Kyowa Kirin Business Overview
Table 102. Kyowa Kirin Androgen Replacement Therapy Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 103. Kyowa Kirin Androgen Replacement Therapy Product
Table 104. Kyowa Kirin Response to COVID-19 and Related Developments
Table 105. Acerus Pharmaceuticals Business Overview
Table 106. Acerus Pharmaceuticals Androgen Replacement Therapy Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 107. Acerus Pharmaceuticals Androgen Replacement Therapy Product
Table 108. Acerus Pharmaceuticals Response to COVID-19 and Related Developments
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Androgen Replacement Therapy Assessment
Table 9. COVID-19 Impact: Androgen Replacement Therapy Market Trends
Table 10. COVID-19 Impact Global Androgen Replacement Therapy Market Size
Table 11. Global Androgen Replacement Therapy Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Androgen Replacement Therapy Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Androgen Replacement Therapy Market Growth Drivers
Table 14. Global Androgen Replacement Therapy Market Restraints
Table 15. Global Androgen Replacement Therapy Market Opportunities
Table 16. Global Androgen Replacement Therapy Market Challenges
Table 17. By Players, Androgen Replacement Therapy Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Androgen Replacement Therapy Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Androgen Replacement Therapy Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Androgen Replacement Therapy Market
Table 21. Key Players Androgen Replacement Therapy Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Androgen Replacement Therapy Market Size 2019-2021, (US$ Million)
Table 24. Global Androgen Replacement Therapy Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Androgen Replacement Therapy Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Androgen Replacement Therapy Market Size, 2019-2021 (US$ Million)
Table 57. AbbVie Business Overview
Table 58. AbbVie Androgen Replacement Therapy Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. AbbVie Androgen Replacement Therapy Product
Table 60. AbbVie Response to COVID-19 and Related Developments
Table 61. Endo International Business Overview
Table 62. Endo International Androgen Replacement Therapy Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Endo International Androgen Replacement Therapy Product
Table 64. Endo International Response to COVID-19 and Related Developments
Table 65. Eli lilly Business Overview
Table 66. Eli lilly Androgen Replacement Therapy Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Eli lilly Androgen Replacement Therapy Product
Table 68. Eli lilly Response to COVID-19 and Related Developments
Table 69. Pfizer Business Overview
Table 70. Pfizer Androgen Replacement Therapy Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Pfizer Androgen Replacement Therapy Product
Table 72. Pfizer Response to COVID-19 and Related Developments
Table 73. Actavis (Allergan) Business Overview
Table 74. Actavis (Allergan) Androgen Replacement Therapy Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Actavis (Allergan) Androgen Replacement Therapy Product
Table 76. Actavis (Allergan) Response to COVID-19 and Related Developments
Table 77. Bayer Business Overview
Table 78. Bayer Androgen Replacement Therapy Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Bayer Androgen Replacement Therapy Product
Table 80. Bayer Response to COVID-19 and Related Developments
Table 81. Novartis Business Overview
Table 82. Novartis Androgen Replacement Therapy Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Novartis Androgen Replacement Therapy Product
Table 84. Novartis Response to COVID-19 and Related Developments
Table 85. Teva Business Overview
Table 86. Teva Androgen Replacement Therapy Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Teva Androgen Replacement Therapy Product
Table 88. Teva Response to COVID-19 and Related Developments
Table 89. Mylan Business Overview
Table 90. Mylan Androgen Replacement Therapy Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Mylan Androgen Replacement Therapy Product
Table 92. Mylan Response to COVID-19 and Related Developments
Table 93. Upsher-Smith Business Overview
Table 94. Upsher-Smith Androgen Replacement Therapy Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Upsher-Smith Androgen Replacement Therapy Product
Table 96. Upsher-Smith Response to COVID-19 and Related Developments
Table 97. Ferring Pharmaceuticals Business Overview
Table 98. Ferring Pharmaceuticals Androgen Replacement Therapy Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Ferring Pharmaceuticals Androgen Replacement Therapy Product
Table 100. Ferring Pharmaceuticals Response to COVID-19 and Related Developments
Table 101. Kyowa Kirin Business Overview
Table 102. Kyowa Kirin Androgen Replacement Therapy Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 103. Kyowa Kirin Androgen Replacement Therapy Product
Table 104. Kyowa Kirin Response to COVID-19 and Related Developments
Table 105. Acerus Pharmaceuticals Business Overview
Table 106. Acerus Pharmaceuticals Androgen Replacement Therapy Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 107. Acerus Pharmaceuticals Androgen Replacement Therapy Product
Table 108. Acerus Pharmaceuticals Response to COVID-19 and Related Developments
LIST OF FIGURES
Figure 1. Androgen Replacement Therapy Product Picture
Figure 2. Androgen Replacement Therapy Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Androgen Replacement Therapy Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Androgen Replacement Therapy Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Androgen Replacement Therapy Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Androgen Replacement Therapy Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Androgen Replacement Therapy Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Androgen Replacement Therapy Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Androgen Replacement Therapy Market Size Market Share, 2019-2021
Figure 1. Androgen Replacement Therapy Product Picture
Figure 2. Androgen Replacement Therapy Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Androgen Replacement Therapy Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Androgen Replacement Therapy Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Androgen Replacement Therapy Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Androgen Replacement Therapy Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Androgen Replacement Therapy Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Androgen Replacement Therapy Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Androgen Replacement Therapy Market Size Market Share, 2019-2021
